Overview:

The rates of prostate cancer continue to increase due to an aging population and this trend will continue as the Baby Boom generation (born between 1946 and 1964) enter their peak prostate cancer years. Furthermore, men are being diagnosed at younger ages and survival rates are increasingly magnifying the impact of side-effects and complications. This course will explore how these factors will force modification of treatment strategies. The course director and proposed faculty will use specific case presentations to highlight these challenges and opportunities.

Objectives: After attending this course, the participants should be able to:

• identify the current trends in prostate cancer epidemiology and treatment for the Baby Boom generation
• illustrate changing treatment trends in the management of localized prostate cancer that seek to optimize disease control and limit side effects such as impotence and incontinence
• explore recent management strategies for prostate specific antigen (PSA) recurrence and hormone refractory prostate cancer (HRPC) that attempt to limit toxicities such as the side-effects of hormonal therapy and SRE’s

In approximately 30 days the AUA will be conducting a follow-up survey in conjunction with Outcomes, Inc. to assess the impact of this educational activity on your practice.  Your participation in this short follow-up survey will help us develop future CME programming to meet your needs. An incentive will be provided for your time and participation.

If you wish to apply for CME for these lectures, please log in first.